Cargando…

Hypoxia-induced pulmonary hypertension and chronic lung disease: caveolin-1 dysfunction an important underlying feature

Caveolin-1 (cav-1) has been shown to play a significant role in the pathogenesis of pulmonary hypertension (PH). In the monocrotaline model of PH, the loss of endothelial cav-1 as well as reciprocal activation of proliferative and anti-apoptotic pathways initiate the disease process and facilitate i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Jing, Frid, Maria, Gewitz, Michael H., Fallon, John T., Brown, Dale, Krafsur, Greta, Stenmark, Kurt, Mathew, Rajamma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434444/ https://www.ncbi.nlm.nih.gov/pubmed/30806156 http://dx.doi.org/10.1177/2045894019837876

Ejemplares similares

Critical Role of Caveolin-1 Loss/Dysfunction in Pulmonary Hypertension
por: Mathew, Rajamma
Publicado: (2021)

Hematological disorders and pulmonary hypertension
por: Mathew, Rajamma, et al.
Publicado: (2016)

Cell-Specific Dual Role of Caveolin-1 in Pulmonary Hypertension
por: Mathew, Rajamma
Publicado: (2011)

Associated inflammation or increased flow-mediated shear stress, but not pressure alone, disrupts endothelial caveolin-1 in infants with pulmonary hypertension
por: Dereddy, Narendra, et al.
Publicado: (2012)

Circulating MicroRNA Markers for Pulmonary Hypertension in Supervised Exercise Intervention and Nightly Oxygen Intervention
por: Grunig, Gabriele, et al.
Publicado: (2018)

Signaling Pathways Involved in the Development of Bronchopulmonary Dysplasia and Pulmonary Hypertension
por: Mathew, Rajamma
Publicado: (2020)

Brief Report: Case Comparison of Therapy With the Histone Deacetylase Inhibitor Vorinostat in a Neonatal Calf Model of Pulmonary Hypertension
por: Applegate, Tanya J., et al.
Publicado: (2021)

Cardiopulmonary remodeling in fattened beef cattle: a naturally occurring large animal model of obesity-associated pulmonary hypertension with left heart disease
por: Krafsur, Greta M., et al.
Publicado: (2018)

RNA-Binding Proteins in Pulmonary Hypertension
por: Zhang, Hui, et al.
Publicado: (2020)

Characterizing the impact of altitude and finishing system on mean pulmonary arterial pressure and carcass characteristics in Angus cattle
por: Jennings, Kaysie J, et al.
Publicado: (2019)

Metabolic Deregulation in Pulmonary Hypertension
por: Mathew, Rajamma, et al.
Publicado: (2023)

Inflammation, immunity, and vascular remodeling in pulmonary hypertension; Evidence for complement involvement?
por: Frid, Maria G., et al.
Publicado: (2020)

Pulmonary Agenesis and Associated Pulmonary Hypertension: A Case Report and Review on Variability, Therapy, and Outcome
por: Muensterer, Oliver, et al.
Publicado: (2015)

Pulmonary Hypertension Remodels the Genomic Fabrics of Major Functional Pathways
por: Mathew, Rajamma, et al.
Publicado: (2020)

Progenitor cells in pulmonary vascular remodeling
por: Yeager, Michael E., et al.
Publicado: (2011)

Targeting the adventitial microenvironment in pulmonary hypertension: A potential approach to therapy that considers epigenetic change
por: Stenmark, Kurt R., et al.
Publicado: (2012)

The Short-Chain Fatty Acid Butyrate Attenuates Pulmonary Vascular Remodeling and Inflammation in Hypoxia-Induced Pulmonary Hypertension
por: Karoor, Vijaya, et al.
Publicado: (2021)

Caveolin-1 accelerates hypoxia-induced endothelial dysfunction in high-altitude cerebral edema
por: Xue, Yan, et al.
Publicado: (2022)

Microenvironmental Regulation of Macrophage Transcriptomic and Metabolomic Profiles in Pulmonary Hypertension
por: Li, Min, et al.
Publicado: (2021)

Caveolae, caveolin-1 and cavin-1: Emerging roles in pulmonary hypertension
por: Chettimada, Sukrutha, et al.
Publicado: (2015)

JNK2 regulates vascular remodeling in pulmonary hypertension
por: Das, Mita, et al.
Publicado: (2018)

Serum Caveolin-1 as a Novel Biomarker in Idiopathic Pulmonary Artery Hypertension
por: Wang, Kuo-Yang, et al.
Publicado: (2015)

Caveolin‐1 associated with severe (pediatric‐onset) presentation of pulmonary arterial hypertension
por: Farrell, Rachel, et al.
Publicado: (2022)

Mechanisms Contributing to the Dysregulation of miRNA-124 in Pulmonary Hypertension
por: Zhang, Hui, et al.
Publicado: (2021)

TGF-β activation by bone marrow-derived thrombospondin-1 causes Schistosoma- and hypoxia-induced pulmonary hypertension
por: Kumar, Rahul, et al.
Publicado: (2017)

Mechanics and mechanisms of pulmonary hypertension: An introduction to the 55(th) annual Thomas L. Petty Aspen Lung Conference
por: Bull, Todd M., et al.
Publicado: (2013)

Mechanisms contributing to persistently activated cell phenotypes in pulmonary hypertension
por: Hu, Cheng‐Jun, et al.
Publicado: (2018)

The zinc transporter, ZIP12, regulates the pulmonary vascular response to chronic hypoxia
por: Zhao, Lan, et al.
Publicado: (2015)

NDRG1 promotes endothelial dysfunction and hypoxia-induced pulmonary hypertension by targeting TAF15
por: Li, Chengwei, et al.
Publicado: (2023)

Caveolin-1, cellular senescence and pulmonary emphysema
por: Volonte, Daniela, et al.
Publicado: (2009)

Activation of the unfolded protein response is associated with pulmonary hypertension
por: Yeager, Michael E., et al.
Publicado: (2012)

Endothelial PHD2 deficiency induces nitrative stress via suppression of caveolin-1 in pulmonary hypertension
por: Liu, Bin, et al.
Publicado: (2022)

Increased prevalence of EPAS1 variant in cattle with high-altitude pulmonary hypertension
por: Newman, John H., et al.
Publicado: (2015)

The importance of caveolins and caveolae to dermatology: Lessons from the caves and beyond
por: Egger, Andjela N., et al.
Publicado: (2020)

The importance of caveolin as a target in the prevention and treatment of diabetic cardiomyopathy
por: Xia, Weiyi, et al.
Publicado: (2022)

Important Role of Endogenous Nerve Growth Factor Receptor in the Pathogenesis of Hypoxia-Induced Pulmonary Hypertension in Mice
por: Goten, Chiaki, et al.
Publicado: (2023)

Biomarkers for Pediatric Pulmonary Arterial Hypertension – A Call to Collaborate
por: Colvin, Kelley L., et al.
Publicado: (2014)

Treatment Targets for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
por: Prisco, Sasha Z., et al.
Publicado: (2020)

A current view of G protein-coupled receptor - mediated signaling in pulmonary hypertension: finding opportunities for therapeutic intervention
por: Strassheim, Derek, et al.
Publicado: (2018)

Exercise cardiac MRI unmasks right ventricular dysfunction in acute hypoxia and chronic pulmonary arterial hypertension
por: Jaijee, Shareen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mmnnt1kclras584tn0r72k2hov